Antibiotics - 2/11

Entry	Author	Date	Location
Cubist Settles Key Litigation	Ryan McBride	04/05/11	Boston
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made	Luke Timmerman	04/04/11	National
Optimer Nabs $68M in Stock Sale	Luke Timmerman	02/11/11	San Diego
Optimer Pockets $68M Upfront From Astellas For Rights to Antibiotic in Europe	Luke Timmerman	02/07/11	San Diego
Rib-X Raises Another $20M, Led by Warburg Pincus, to Develop Late Stage Antibiotics	Luke Timmerman	01/11/11	Boston
E-Commerce Pioneer Sets Up Cancer Commons, Affymax Hires New Boss, Plexxikon Opts In, & More Bay Area Life Sciences News	Luke Timmerman	01/07/11	San Francisco
Genentech Licenses AMRI Compounds	Luke Timmerman	01/04/11	Seattle
Avalon Funds Antibiotics Development at New Startup, RQx Pharmaceuticals	Bruce V. Bigelow	12/14/10	San Diego
Optimer Seeks Quick Green Light From FDA for Antibiotic Against Deadly Bug	Luke Timmerman	11/30/10	San Diego
Glaxo Buys $129M in Theravance Stock	Luke Timmerman	11/29/10	San Francisco
Optimer Halts Study After Antibiotic for Traveler’s Diarrhea Linked to Rash; Shares Drop	Luke Timmerman	11/10/10	San Diego
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News	Luke Timmerman	09/24/10	San Francisco
AvidBiotics Creates Novel Proteins that Kill Bacteria on the Farm, in the Lab, in the Body	Luke Timmerman	09/21/10	San Francisco
Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference	Luke Timmerman	09/15/10	Boston
Why We Think Investing in Antibiotics Makes Sense	Stephen Bloch	09/14/10	San Francisco
Trius Ends First Day Trading at $5 a Share	Bruce V. Bigelow	08/03/10	San Diego
Trius Chops IPO Price, Offers More Shares	Bruce V. Bigelow	08/02/10	San Diego
Optimer Seeks EU Approval	Luke Timmerman	07/29/10	San Diego
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics	Luke Timmerman	07/19/10	San Francisco
Trius IPO Plans Back on Track	Bruce V. Bigelow	07/15/10	San Diego
$4.5M for Excelimmune	Ryan McBride	07/07/10	Boston
Trius Gets FDA Clarity	Luke Timmerman	06/16/10	San Diego
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News	Erin Kutz	06/04/10	Boston
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics	Luke Timmerman	06/01/10	Boston
Trius Gets $29.5M Defense Contract	Bruce V. Bigelow	05/20/10	San Diego
Clinical Data Seeks to Challenge Lilly, Pfizer in Antidepressant Market	Ryan McBride	05/11/10	Boston
Optimer Hires New CEO	Luke Timmerman	05/06/10	San Diego
Amplyx Pharmaceuticals, Led By Women, Builds Platform for Improving Drugs for HIV, Cancer	Luke Timmerman	04/20/10	San Diego
Frazier, Arch Join $56M Antibiotic Deal	Luke Timmerman	04/07/10	Seattle
Former Targanta CEO Leuchtenberger Lands New Gig at Rib-X, Another Antibiotic Company	Luke Timmerman	03/23/10	Boston
Page 2 of 4	« previous page · next page »

Entry

Author

Date

Location

Cubist Settles Key Litigation

Ryan McBride

04/05/11

Boston

Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made

Luke Timmerman

04/04/11

National